-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2021 to 2024.
- BioXcel Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $10.9M, a 46.4% decline year-over-year.
- BioXcel Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $69.5M, a 59.9% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Costs and Expenses for 2024 was $69.5M, a 59.9% decline from 2023.
- BioXcel Therapeutics, Inc. annual Costs and Expenses for 2023 was $173M, a 8.21% increase from 2022.
- BioXcel Therapeutics, Inc. annual Costs and Expenses for 2022 was $160M, a 49.6% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)